FIELD: medicine.
SUBSTANCE: what is presented is a nucleic acid construct for treating tumours comprising at least two open reading frames that include sequences encoding a cytotoxic or cytostatic gene product, in particular diphtheria toxin functionally related to various tumour-specific promoters: H19-specific promoter, IGF-II P3 or P4 promoter. What is described is a eukaryotic expression vector comprising the above nucleic acid construct, and methods of treating and inhibiting the tumour development in a human subject by administering the nucleic acid construct under the invention.
EFFECT: invention can find further application in therapy of cancer.
33 cl, 12 ex, 40 dwg
Authors
Dates
2013-07-10—Published
2008-10-23—Filed